| Chronic Kidney Disease |
1 |
1 |
| Renal Failure |
0 |
0.9 |
| Kidney |
0 |
0.67 |
| Renal Disease |
0 |
0.67 |
| Cardiovascular Risk Management |
0 |
0.63 |
| Coronary Artery Disease (CAD) |
0 |
0.5 |
| Hypertension |
0 |
0.36 |
| Biomarker |
0 |
0.33 |
| Heart Failure (HF) |
0 |
0.32 |
| Heart |
0 |
0.28 |
| Cardiovascular disease |
0 |
0.24 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.24 |
| Lipids Management |
0 |
0.2 |
| Troponin |
0 |
0.19 |
| Cerebrovascular Accident |
0 |
0.15 |
| Pulmonary Embolism |
0 |
0.15 |
| Blood |
0 |
0.14 |
| Injury |
0 |
0.14 |
| Translational Research |
0 |
0.14 |
| Deep Venous Thrombosis |
0 |
0.13 |
| Hemoglobin |
0 |
0.1 |
| Hemoglobin A1c |
0 |
0.1 |
| Shared Decision-Making |
0 |
0.1 |
| Wound Management |
0 |
0.1 |
| Tobacco Cessation |
0 |
0.09 |
| Tobacco Use |
0 |
0.08 |
| B-Type Natriuretic Peptide |
0 |
0.07 |
| Myocardial Infarction (MI) |
0 |
0.06 |
| Apolipoproteins |
0 |
0.05 |
| Brain |
0 |
0.05 |
| C-Reactive Protein (CRP) |
0 |
0.05 |
| Child |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Group Practice |
0 |
0.05 |
| Health Care Cost |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Illinois |
0 |
0.05 |
| Maryland |
0 |
0.05 |
| Michigan |
0 |
0.05 |
| Pennsylvania |
0 |
0.05 |
| Primary Care |
0 |
0.05 |
| Smoking |
0 |
0.05 |
| Wisconsin |
0 |
0.05 |